MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 70 filers reported holding MONTE ROSA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,542 | +2.4% | 2,893,717 | 0.0% | 1.48% | +0.7% |
| Q4 2022 | $22,021 | -99.9% | 2,893,717 | -3.3% | 1.47% | -13.8% |
| Q3 2022 | $24,459,000 | -15.5% | 2,993,717 | 0.0% | 1.71% | -21.9% |
| Q2 2022 | $28,949,000 | -31.2% | 2,993,717 | -0.3% | 2.19% | -32.3% |
| Q1 2022 | $42,091,000 | -31.3% | 3,002,199 | 0.0% | 3.23% | -11.4% |
| Q4 2021 | $61,305,000 | -9.8% | 3,002,199 | -3.2% | 3.65% | +32.1% |
| Q3 2021 | $67,957,000 | -2.3% | 3,102,199 | -2.9% | 2.76% | +16.8% |
| Q2 2021 | $69,550,000 | – | 3,193,973 | – | 2.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $11,469,458 | 5.52% |
| NEA Management Company, LLC | 7,692,298 | $59,923,001 | 4.14% |
| Cormorant Asset Management, LP | 2,893,717 | $22,542 | 1.48% |
| Alphabet Inc. | 1,464,015 | $11,404,677 | 0.63% |
| Avoro Capital Advisors LLC | 4,325,000 | $33,691,750 | 0.50% |
| Casdin Capital, LLC | 510,882 | $3,979,771 | 0.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $242,705 | 0.10% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $219,616 | 0.04% |
| UBS OCONNOR LLC | 95,528 | $744,163 | 0.02% |
| ExodusPoint Capital Management, LP | 261,593 | $2,038 | 0.02% |